• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病注册协会痴呆行为评定量表。阿尔茨海默病注册协会行为病理学委员会。

The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease. The Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease.

作者信息

Tariot P N, Mack J L, Patterson M B, Edland S D, Weiner M F, Fillenbaum G, Blazina L, Teri L, Rubin E, Mortimer J A

机构信息

University of Rochester School of Medicine, N.Y., USA.

出版信息

Am J Psychiatry. 1995 Sep;152(9):1349-57. doi: 10.1176/ajp.152.9.1349.

DOI:10.1176/ajp.152.9.1349
PMID:7653692
Abstract

OBJECTIVE

The purpose of the study was to develop a standardized instrument, the Behavior Rating Scale for Dementia, for rating psychopathology in patients with probable Alzheimer's disease and to conduct a multicenter pilot study of this instrument.

METHOD

The rating scale was developed collaboratively on the basis of clinical experience and existing instruments. Items were scaled according to frequency of psychopathology and were administered to an informant who was familiar with the subject. The scale was administered in a standardized manner by trained examiners who had met predetermined certification standards. The study group consisted of 303 subjects with probable Alzheimer's disease who had undergone standardized clinical evaluations by the Consortium to Establish a Registry for Alzheimer's Disease.

RESULTS

Subjects had an average of 15 problems rated as present in the preceding month. Wide variability in the nature of disturbances was found, with a number of items rated as present since the illness began but not in the past month. Interrater agreement was high. Factor analysis suggested eight preliminary factors that mapped onto clinically relevant domains: depressive features, psychotic features, defective self-regulation, irritability/agitation, vegetative features, apathy, aggression, and affective lability.

CONCLUSIONS

The Behavior Rating Scale for Dementia provides a standardized, reliable measure that can be administered to caregivers of demented subjects. On the basis of the present study, the scale has been revised slightly. After additional studies in progress, the Behavior Rating Scale for Dementia will be available for general use in assessing a wide range of psychopathology in dementia.

摘要

目的

本研究旨在开发一种标准化工具——痴呆行为评定量表,用于对可能患有阿尔茨海默病的患者的精神病理学进行评定,并对该工具进行多中心试点研究。

方法

该评定量表是在临床经验和现有工具的基础上合作开发的。项目根据精神病理学的发生频率进行评分,并由熟悉受试者情况的知情者进行评定。该量表由符合预定认证标准的经过培训的检查人员以标准化方式进行评定。研究组由303名可能患有阿尔茨海默病的受试者组成,这些受试者均接受了阿尔茨海默病注册协会的标准化临床评估。

结果

受试者在前一个月平均有15个被评定为存在的问题。发现干扰的性质存在很大差异,许多项目自疾病开始就被评定为存在,但在过去一个月中并非如此。评分者间的一致性很高。因子分析表明有八个初步因子,这些因子对应于临床相关领域:抑郁特征、精神病性特征、自我调节缺陷、易激惹/激越、植物神经功能特征、淡漠、攻击行为和情感不稳定。

结论

痴呆行为评定量表提供了一种标准化、可靠的测量方法,可用于对痴呆患者的照料者进行评定。基于本研究,该量表已进行了轻微修订。在正在进行的进一步研究之后,痴呆行为评定量表将可广泛用于评估痴呆患者的各种精神病理学表现。

相似文献

1
The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease. The Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease.阿尔茨海默病注册协会痴呆行为评定量表。阿尔茨海默病注册协会行为病理学委员会。
Am J Psychiatry. 1995 Sep;152(9):1349-57. doi: 10.1176/ajp.152.9.1349.
2
Behavior Rating Scale for Dementia: development of test scales and presentation of data for 555 individuals with Alzheimer's disease.痴呆行为评定量表:测试量表的编制及555例阿尔茨海默病患者的数据呈现
J Geriatr Psychiatry Neurol. 1999 Winter;12(4):211-23. doi: 10.1177/089198879901200408.
3
A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer's disease.阿尔茨海默病重度抑郁综合征的出现及临床特征的合作研究。
Am J Psychiatry. 2003 May;160(5):857-66. doi: 10.1176/appi.ajp.160.5.857.
4
Syndromic validity of apathy in Alzheimer's disease.阿尔茨海默病中淡漠症状的综合征效度
Am J Psychiatry. 2001 Jun;158(6):872-7. doi: 10.1176/appi.ajp.158.6.872.
5
Performance-Based instrument to assess functional capacity in dementia: The Texas Functional Living Scale.基于表现的痴呆症功能能力评估工具:德克萨斯功能生活量表。
Neuropsychiatry Neuropsychol Behav Neurol. 2001 Apr-Jun;14(2):103-8.
6
Assessment of agitation in Alzheimer's disease: the agitated behavior in dementia scale. Alzheimer's Disease Cooperative Study.阿尔茨海默病中激越的评估:痴呆激越行为量表。阿尔茨海默病协作研究。
J Am Geriatr Soc. 1999 Nov;47(11):1354-8. doi: 10.1111/j.1532-5415.1999.tb07439.x.
7
[Noncognitive symptoms in Alzheimer's disease. A study of 150 community-dwelling patients using a questionnaire completed by the caregiver].[阿尔茨海默病的非认知症状。对150名社区居住患者进行的研究,采用由照料者填写的问卷]
Rev Neurol (Paris). 2001 Feb;157(2):162-77.
8
[The clinical picture and stability of non-cognitive symptoms in patients with Alzheimer's disease].[阿尔茨海默病患者非认知症状的临床表现及稳定性]
Fortschr Neurol Psychiatr. 1998 May;66(5):233-40. doi: 10.1055/s-2007-995259.
9
The construct of minor and major depression in Alzheimer's disease.阿尔茨海默病中轻度和重度抑郁的结构
Am J Psychiatry. 2005 Nov;162(11):2086-93. doi: 10.1176/appi.ajp.162.11.2086.
10
A new rating scale for Alzheimer's disease.一种用于阿尔茨海默病的新评定量表。
Am J Psychiatry. 1984 Nov;141(11):1356-64. doi: 10.1176/ajp.141.11.1356.

引用本文的文献

1
Identifying instruments for measuring agitation and other non-cognitive symptoms in people with advanced dementia in residential settings: a scoping review protocol.识别用于测量居住环境中晚期痴呆患者激越及其他非认知症状的工具:一项范围综述方案
BMJ Open. 2025 Aug 12;15(8):e096540. doi: 10.1136/bmjopen-2024-096540.
2
The Experience of Caregivers of Older Adults With Dementia in Using Telemedicine in a Primary Care Setting of Canada During COVID-19.新冠疫情期间加拿大基层医疗环境下老年痴呆症患者照料者使用远程医疗的经历
Can Geriatr J. 2025 Jun 4;28(2):125-135. doi: 10.5770/cgj.28.825. eCollection 2025 Jun.
3
Structural Neuroimaging Correlates of Neuropsychiatric Symptoms in Alzheimer's Disease: A Systematic Literature Review.
阿尔茨海默病神经精神症状的结构神经影像学关联:一项系统文献综述
Dement Geriatr Cogn Disord. 2025 Feb 12:1-15. doi: 10.1159/000543160.
4
A brain DNA co-methylation network analysis of psychosis in Alzheimer's disease.阿尔茨海默病精神病的脑DNA共甲基化网络分析
Alzheimers Dement. 2025 Feb;21(2):e14501. doi: 10.1002/alz.14501.
5
Behavioral symptoms and treatment challenges for patients living with dementia: Hospice clinician and caregiver perspectives.痴呆症患者的行为症状及治疗挑战:临终关怀临床医生和护理人员的观点
J Am Geriatr Soc. 2025 Apr;73(4):1094-1104. doi: 10.1111/jgs.19320. Epub 2024 Dec 16.
6
Assessing behavioral and psychological symptoms of dementia: a comprehensive review of current options and future perspectives.评估痴呆的行为和心理症状:当前方法及未来展望的全面综述
Front Dement. 2023 Jul 25;2:1226060. doi: 10.3389/frdem.2023.1226060. eCollection 2023.
7
Psychosis detection in dementia: a systematic review of diagnostic test accuracy studies.痴呆症中的精神病检测:诊断试验准确性研究的系统评价
Front Dement. 2024 Jun 13;3:1377191. doi: 10.3389/frdem.2024.1377191. eCollection 2024.
8
Genetic associations with psychosis and affective disturbance in Alzheimer's disease.阿尔茨海默病中与精神病和情感障碍的基因关联。
Alzheimers Dement (N Y). 2024 May 23;10(2):e12472. doi: 10.1002/trc2.12472. eCollection 2024 Apr-Jun.
9
A Unique Delusion with Depression in Early Stage of Neurocognitive Disorder Due to Vascular Disease: Considerations for Clinicians.血管性疾病所致神经认知障碍早期伴发抑郁的独特妄想:临床医生的思考。
Psychopharmacol Bull. 2024 Apr 4;54(2):28-33.
10
The Interface between Depression and Alzheimer's Disease. A Comprehensive Approach.抑郁症与阿尔茨海默病的关联。一种综合方法。
Ann Indian Acad Neurol. 2023 Jul-Aug;26(4):315-325. doi: 10.4103/aian.aian_326_23. Epub 2023 Sep 11.